Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

Study reveals how cells regulate repair protein production to prevent DNA damage over-repair or under-repair, aiding cell ...

According to a new comprehensive report from The Insight Partners, the global mRNA sequencing market is observing ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

There’s a big lesson here for right-wing, populist politicians and parties. Trafficking in conspiracy theories to get votes ...

Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.

Discover the bioanalytical strategies crucial for unlocking the potential of LNP-mRNA vaccines. Explore the impact of these strategies on the development and efficacy of mRNA vaccines.